Your browser doesn't support javascript.
loading
Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.
Nishino, Masaya; Suda, Kenichi; Kobayashi, Yoshihisa; Ohara, Shuta; Fujino, Toshio; Koga, Takamasa; Chiba, Masato; Shimoji, Masaki; Tomizawa, Kenji; Takemoto, Toshiki; Mitsudomi, Tetsuya.
Afiliación
  • Nishino M; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Suda K; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Kobayashi Y; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Ohara S; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Fujino T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Koga T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Chiba M; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Shimoji M; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Tomizawa K; Department of Thoracic Surgery, Izumi City General Hospital, Izumi, Osaka, Japan.
  • Takemoto T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Mitsudomi T; Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. Electronic address: mitsudom@med.kindai.ac.jp.
Lung Cancer ; 126: 149-155, 2018 12.
Article en En | MEDLINE | ID: mdl-30527179

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acrilamidas / Resistencia a Antineoplásicos / Receptores ErbB / Compuestos de Anilina / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acrilamidas / Resistencia a Antineoplásicos / Receptores ErbB / Compuestos de Anilina / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón